BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22281667)

  • 1. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).
    de Oliveira AT; Pinheiro C; Longatto-Filho A; Brito MJ; Martinho O; Matos D; Carvalho AL; Vazquez VL; Silva TB; Scapulatempo C; Saad SS; Reis RM; Baltazar F
    J Bioenerg Biomembr; 2012 Feb; 44(1):171-8. PubMed ID: 22281667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
    Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
    Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
    BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.
    Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F
    J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.
    Benton CR; Yoshida Y; Lally J; Han XX; Hatta H; Bonen A
    Physiol Genomics; 2008 Sep; 35(1):45-54. PubMed ID: 18523157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
    Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
    J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
    Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
    Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
    Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
    Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
    Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
    Celestino R; Lima J; Faustino A; Vinagre J; Máximo V; Gouveia A; Soares P; Lopes JM
    Eur J Hum Genet; 2013 May; 21(5):503-10. PubMed ID: 22948025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
    Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
    Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma: Diagnostic and Therapeutic Implications.
    Choi JW; Lee Y; Kim H; Cho HY; Min SK; Kim YS
    Am J Surg Pathol; 2022 Feb; 46(2):241-248. PubMed ID: 34619707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
    Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
    Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.